What is the ROE (Return on Equity) of DocGo this year?
The ROE of DocGo this year is 0.02 undefined.
DocGo ROE 2024
DocGo ROE
0.02
Ticker
DCGO
ISIN
US2560861096
In 2024, DocGo's return on equity (ROE) was 0.02, a -82% increase from the 0.13 ROE in the previous year.
DocGo Aktienanalyse
What does DocGo do?
The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding DocGo's Return on Equity (ROE)
DocGo's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing DocGo's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
DocGo's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in DocGo’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about DocGo stock
How has the Return on Equity (ROE) of DocGo developed compared to the previous year?
The ROE of DocGo has increased by -82% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of DocGo?
A high ROE indicates that DocGo generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of DocGo?
A low ROE can indicate that DocGo is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of DocGo affect the company?
A change in ROE (Return on Equity) of DocGo can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of DocGo?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of DocGo?
Some factors that can influence DocGo's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does DocGo pay?
Over the past 12 months, DocGo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DocGo is expected to pay a dividend of 0 USD.
What is the dividend yield of DocGo?
The current dividend yield of DocGo is .
When does DocGo pay dividends?
DocGo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DocGo?
DocGo paid dividends every year for the past 0 years.
What is the dividend of DocGo?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is DocGo located?
DocGo is assigned to the 'Health' sector.
Wann musste ich die Aktien von DocGo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DocGo from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.
When did DocGo pay the last dividend?
The last dividend was paid out on 8/25/2024.
What was the dividend of DocGo in the year 2023?
In the year 2023, DocGo distributed 0 USD as dividends.
In which currency does DocGo pay out the dividend?
The dividends of DocGo are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DocGo
Our stock analysis for DocGo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocGo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.